Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
NYSE:BSX
Total Valuation
Boston Scientific has a market cap or net worth of $154.04B. The enterprise value is $161.74B.
Market Cap$154.04B
Enterprise Value$161.74B
Share Statistics
Boston Scientific has 1,479,446,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,479,446,300
Owned by Insiders0.18%
Owned by Institutions0.50%
Financial Efficiency
Boston Scientific’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.06%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.06%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee315.98K
Profits Per Employee34.83K
Employee Count53,000
Asset Turnover0.43
Inventory Turnover1.87
Valuation Ratios
The current PE Ratio of Boston Scientific is 70.89. Boston Scientific’s PEG ratio is 4.25.
PE Ratio70.89
PS Ratio0.00
PB Ratio6.04
Price to Fair Value6.04
Price to FCF49.69
Price to Operating Cash Flow38.26
PEG Ratio4.25
Income Statement
In the last 12 months, Boston Scientific had revenue of 16.75B and earned 1.85B in profits. Earnings per share was 1.26.
Revenue16.75B
Gross Profit11.49B
Operating Income2.60B
Pretax Income2.28B
Net Income1.85B
EBITDA3.94B
Earnings Per Share (EPS)1.26
Cash Flow
In the last 12 months, operating cash flow was 3.81B and capital expenditures -939.00M, giving a free cash flow of 2.87B billion.
Operating Cash Flow3.81B
Free Cash Flow2.87B
Free Cash Flow per Share1.94
Dividends & Yields
Boston Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change41.43%
50-Day Moving Average99.23
200-Day Moving Average90.99
Relative Strength Index (RSI)64.12
Average Volume (3m)9.35M
Important Dates
Boston Scientific upcoming earnings date is Jul 23, 2025, TBA Not Confirmed.
Last Earnings DateApr 23, 2025
Next Earnings DateJul 23, 2025
Ex-Dividend Date―
Financial Position
Boston Scientific as a current ratio of 1.08, with Debt / Equity ratio of 52.71%
Current Ratio1.08
Quick Ratio0.64
Debt to Market Cap0.08
Net Debt to EBITDA2.72
Interest Coverage Ratio8.53
Taxes
In the past 12 months, Boston Scientific has paid 436.00M in taxes.
Income Tax436.00M
Effective Tax Rate0.19
Enterprise Valuation
Boston Scientific EV to EBITDA ratio is 36.08, with an EV/FCF ratio of 53.75.
EV to Sales8.49
EV to EBITDA36.08
EV to Free Cash Flow53.75
EV to Operating Cash Flow41.39
Balance Sheet
Boston Scientific has $725.00M in cash and marketable securities with $11.71B in debt, giving a net cash position of $10.98B billion.
Cash & Marketable Securities$725.00M
Total Debt$11.71B
Net Cash$10.98B
Net Cash Per Share$7.42
Tangible Book Value Per Share-$1.20
Margins
Gross margin is 67.15%, with operating margin of 15.54%, and net profit margin of 11.07%.
Gross Margin67.15%
Operating Margin15.54%
Pretax Margin13.63%
Net Profit Margin11.07%
EBITDA Margin23.53%
EBIT Margin15.45%
Analyst Forecast
The average price target for Boston Scientific is $119.56, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$119.56
Price Target Upside14.08% Upside
Analyst ConsensusStrong Buy
Analyst Count19
Revenue Growth Forecast19.35%
EPS Growth Forecast14.31%